| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |